CARL - Carlsmed, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

CARL

CARLSMED, INC.

NASDAQ

$16.88

▲ UP 0.78% (0.13)

KEY STATISTICS

Market Cap$458.88 M

52w High$17.23

52w Low$8.50

Dividend Yield—

Frequency—

P/E-11.80

Volume121.25K

Shares Out.27.18M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Mike Cordonnier

COMPENSATION 2026

Salary$480,822

Stock Awards$353,218

Incentive Plan Pay$414,709

All Other Comp.$30,848

Total$2,789,967

ABOUT

SECTOR

Healthcare

WENT PUBLIC

July 23, 2025

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

127

PRICE TARGET

Target High$20.00

Target Low$17.00

Target Median$18.50

Target Consensus$18.50

UPCOMING EARNINGS

DateNov 5, 2026

DayThursday

Rev. Est.$19.17M

NOV

THU

PRICE

$16.88 ▲ UP 0.78% (+$0.13)

About Carlsmed, Inc.

https://www.carlsmed.com ↗

Carlsmed, Inc. is a California-based medical tech company that develops AI-enabled personalized spine surgery solutions, including its aprevo platform with surgical planning software and custom vertebral implants.

INDUSTRY

Medical - Devices

A PRODUCT CARLSMED, INC. IS KNOWN FOR

aprevo® Personalized Surgery Platform

The aprevo® platform is an AI-enabled spine surgery solution offering personalized, 3D-printed implants and surgical plans to enhance outcomes and reduce healthcare costs.